-
People with diabetes at higher risk of amid pandemic
pharmatimes
May 21, 2020
NHS England is calling on people with diabetes to access the help available to them after new research showed that those living with the condition are at significantly higher risk of dying with COVID-19.
-
Stevanato Group Collaborates with Cambridge Design Partnership
contractpharma
April 29, 2020
The companies will develop a pen-injector for patients suffering from diabetes together.
-
Dapnat launch to boost Natco’s presence in India’s diabetes market but concerted efforts required, s
expresspharma
April 29, 2020
Natco is a new player within the cardiovascular and diabetes therapeutic space, launching its Cardiology and Diabetic (CnD) division in early 2017.
-
Harvard spins out oral biologic tech with a focus on diabetes
fiercebiotech
April 13, 2020
A new spinout from Harvard University hopes to one day have people with diabetes reach for a bottle of pills instead of the syringe when they need to take their frequent medications.
-
Using fatty acids in oral formulations to improve drug delivery
europeanpharmaceuticalreview
April 07, 2020
Researchers have used triglyceride fatty acids to develop an oral formulation for drugs that are usually injected or taken intravenously.
-
Pancreas app now available for type I diabetics in UK
pharmatimes
March 17, 2020
The world’s first licensed, downloadable artificial pancreas app for people with type I diabetes has been launched in the UK.
-
£12m committed to preventable disease research
pharmatimes
March 16, 2020
The National Institute for Health Research (NIHR) has revealed that the UK Government has committed an extra £12 million to the organisation in 2020/21 for research into preventable diseases.
-
Diasome Announces Positive Results from Hepatocyte Directed Vesicle Study
americanpharmaceuticalreview
March 10, 2020
Diasome Pharmaceuticals announced positive results from its Phase 2 OPTI-1 study of injectable hepatocyte directed vesicle (HDV) added to mealtime insulin in people with type 1 diabetes (T1D).
-
Online pharmacy finds high levels of NDMA in metformin
europeanpharmaceuticalreview
March 09, 2020
Tests conducted by an online pharmacy has revealed high levels of NMDA in the diabetes drug metformin, prompting the company to press for a recall.
-
Bariatric Surgery May Aid T2DM-Related Outcomes at Five Years
drugs
January 20, 2020
Bariatric surgery is associated with weight loss and remission of type 2 diabetes mellitus (T2DM) and dyslipidemia at five years postsurgery, according to a study published online January in Diabetes, Metabolism Research and Reviews.